you are here: HomeNewsBusiness

FM Nirmala Sitharaman pushes large CPSEs to exceed capex target by March

This was the fifth in the ongoing series of meetings that the finance minister is having with various stakeholders to boost the economic growth amid the pandemic.

November 27, 2020 / 08:03 PM IST
Finance Minister Nirmala Sitharaman

Finance Minister Nirmala Sitharaman

Finance Minister Nirmala Sitharaman on Friday exhorted large central public sector enterprises (CPSEs) to exceed their planned capital expenditure (Capex) target for 2020-21 by March to accelerate economic growth hit by the COVID-19 crisis.

She held a virtual meeting with secretaries of power, mines and atomic energy along with the chairman and managing directors (CMDs) of 10 CPSEs, belonging to these ministries, an official statement said.

This was the fifth in the ongoing series of meetings that the finance minister is having with various stakeholders to boost the economic growth amid the pandemic.

While reviewing the performance of CPSEs, Sitharaman said that Capex by CPSEs is a critical driver of economic growth and need to be scaled up for the 2020-21 and 2021-22.

Appreciating the efforts of the ministries and CPSEs for making visible efforts to meet the capital expenditure targets, the finance minister said that "more efforts are still required to achieve the target of 75 percent CAPEX by Q3 and more than 100 percent by Q4 of the FY’21”.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

The overall achievement as on November 23, 2020, is Rs 24,227 crore (39.4 percent) against the Capex target for 2020-21 – Rs 61,483 crore, the statement said.

Sitharaman encouraged the CPSEs to perform better to achieve targets and to ensure that the capital outlay provided to them for the year 2020-21 is spent properly and within time.

The finance minister said the better performance of CPSEs can help the economy in a big way to recover from the impact of COVID-19.

Sitharaman asked the secretaries to closely monitor the performance of CPSEs to ensure to achieve the Capex targets and make plans for it.

She also asked them to proactively sort out the unresolved issues of the CPSEs.
PTI

stay updated

Get Daily News on your Browser
Sections